These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23927675)

  • 1. Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series.
    Thamer M; Zhang Y; Lai D; Kshirsagar O; Cotter D
    BMC Nephrol; 2013 Aug; 14():172. PubMed ID: 23927675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015).
    Park H; Liu X; Henry L; Harman J; Ross EA
    BMC Nephrol; 2018 Nov; 19(1):318. PubMed ID: 30413150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
    Hoque S; Chen BJ; Schoen MW; Carson KR; Keller J; Witherspoon BJ; Knopf KB; Yang YT; Schooley B; Nabhan C; Sartor O; Yarnold PR; Ray P; Bobolts L; Hrushesky WJ; Dickson M; Bennett CL
    PLoS One; 2020; 15(6):e0234541. PubMed ID: 32584835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
    Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
    Seetasith A; Holdford D; Shah A; Patterson J
    Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes.
    Stroupe KT; Tarlov E; Lee TA; Weichle TW; Zhang QL; Michaelis LC; Ozer H; Durazo-Arvizu R; Browning MM; Hynes DM
    Pharmacotherapy; 2012 Nov; 32(11):988-97. PubMed ID: 23108695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.
    Bian J; Chen B; Hershman DL; Marks N; Norris L; Schulz R; Bennett CL
    J Clin Oncol; 2017 Jun; 35(17):1945-1951. PubMed ID: 28441110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008.
    Tarlov E; Stroupe KT; Lee TA; Weichle TW; Zhang QL; Michaelis LC; Ozer H; Browning MM; Hynes DM
    Support Care Cancer; 2012 Aug; 20(8):1649-57. PubMed ID: 21935718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Responsiveness of Health Systems to Drug Safety Warnings.
    Gerlach LB; Kim HM; Yosef M; Sales AE; Stano C; Kales HC; Zivin K
    Am J Geriatr Psychiatry; 2018 Apr; 26(4):476-483. PubMed ID: 29066038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning.
    Krishnamoorthy V; Ellis AR; McLean DJ; Stefan MS; Nathanson BH; Cobert J; Lindenauer PK; Brookhart MA; Ohnuma T; Raghunathan K
    Anesth Analg; 2020 Oct; 131(4):1193-1200. PubMed ID: 32925340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.
    Regidor D; McClellan WM; Kewalramani R; Sharma A; Bradbury BD
    Nephrol Dial Transplant; 2011 May; 26(5):1583-91. PubMed ID: 20861195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the FDA Black Box Suicidality Warnings for Antidepressants on Suicide Rates in the USA.
    Plöderl M; Hengartner MP
    Crisis; 2023 Mar; 44(2):128-134. PubMed ID: 34915730
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.
    Costa NA; Kshirsagar AV; Wang L; Detwiler RK; Brookhart MA
    Transplantation; 2013 Nov; 96(9):807-13. PubMed ID: 23982339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model.
    Suttorp MM; Hoekstra T; Mittelman M; Ott I; Krediet RT; Dekker FW; Putter H
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1068-75. PubMed ID: 26265483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.
    Freburger JK; Ellis AR; Wang L; Butler AM; Kshirsagar AV; Winkelmayer WC; Brookhart MA
    Am J Kidney Dis; 2016 Feb; 67(2):271-82. PubMed ID: 26508682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized anemia management in a dialysis facility - long-term utility as a single-center quality improvement experience
.
    Gaweda AE; Jacobs AA; Aronoff GR; Brier ME
    Clin Nephrol; 2018 Oct; 90(4):276-285. PubMed ID: 30049300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.
    Fuller DS; Bieber BA; Pisoni RL; Li Y; Morgenstern H; Akizawa T; Jacobson SH; Locatelli F; Port FK; Robinson BM
    J Am Soc Nephrol; 2016 Jul; 27(7):2205-15. PubMed ID: 26582402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings.
    Kim HM; Gerlach LB; Yosef M; Stano C; Conroy DA; Valenstein M; Pfeiffer PN; Sales AE; Zivin K
    J Clin Sleep Med; 2018 Jul; 14(7):1135-1141. PubMed ID: 29991420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.